Navigation Links
PCAS : Half Result 2008
Date:7/30/2008


PARIS, July 30 /PRNewswire-FirstCall/ -- 2008 HALF-YEAR RESULTS

EUR'000,000 2008 2007

Revenues 92.5 99.3

EBITDA* 12.9 16.0

EBITDA margin 14.0% 16.1%

Current operating income* 6.0 7.8

Other operating income and expenses 0.4 (2.0)

Financial result (2.8) (2.7)

Net income 2.4 0.8

Shareholders' equity 78.7 73.9

Net debt 69.5 78.0

Gearing 0.88 1.06

* Of which, research tax credit: 0.8 million euros in 2008 and 0 in 2007.

Business and earnings over the first half of 2008 The Group's revenues came to 92.5 million euros over the first half of 2008, compared with 99.3 million euros in H1 2007, down 6.8% (-4.9% at constant exchange rates).

The Pharmaceutical Synthesis division recorded a 10.5% drop, primarily reflecting the impact of:
- The delivery in H1 2007 of an exceptional order produced in 2006 for 4.2

million euros,

- A reduction in finished product stocks with the main client for 2.2

million euros,

- The dollar's depreciation for around 1.0 million euros. In the Fine Specialty Chemicals division, business is down slightly, falling 1.3% (+ 0.9% at constant exchange rates), primarily in light of the continued client portfolio selection policy aimed at eliminating products that are not deemed to be profitable enough.

Despite an unfavorable dollar effect, representing 1.4 margin points or 1.3 million euros for all the divisions, and despite the slowdown in activity, the EBITDA margin came in at 14% (15.4% at constant exchange rates). Current operating income therefore represents 6.0 million euros, compa
'/>"/>

SOURCE PCAS
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sunrise Updates Date and Time of Conference Call to Discuss 2007 Financial Results and Second-Quarter 2008 Preliminary Selected Financial and Operating Data
2. STERIS Corporation Announces Fiscal 2009 First Quarter Results
3. Insulet Corporation to Report Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
4. VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales
5. Symmetry Medical to Report Second Quarter 2008 Financial Results on August 6, 2008
6. Align Technology Announces Second Quarter Fiscal 2008 Results
7. Monogram Announces 2008 Second Quarter Financial Results
8. Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008
9. IPC The Hospitalist Company, Inc. to Report Second Quarter 2008 Financial Results
10. Genomic Health to Announce Second Quarter 2008 Financial Results and Host Conference Call on Tuesday, August 5, 2008
11. Psychemedics Corporation Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Dr. Omar Ibrahimi, Dermatologist and ... CT has been selected as part of a controlled ... (and the only physician in Connecticut) to offer the ... the removal of submental fat (double chin). The procedure ... no surgery and minimal risks. Dr. Ibrahimi is an ...
(Date:5/27/2015)... Clearwater, Florida (PRWEB) May 27, 2015 ... accurate, impartial customer satisfaction surveys in the multiple ... user poll to determine the highest ranked Electronic ... As part of a special research focus on ... and announced those software vendors with the highest ...
(Date:5/27/2015)... Rock, AR (PRWEB) May 27, 2015 ... Medix today announce a partnership to provide CMSA's ... Medix community. This collaboration seeks to strengthen the ... measurement through CMSA’s CKP program. The mutually beneficial ... on identifying individual skills of talent in the ...
(Date:5/27/2015)... 27, 2015 Difass USA, a modern ... U.S. with its first three flagship products, Dormiva™, Relaxiva™ ... nationwide through http://www.difassusa.com . , A restful ... productivity, but some people struggle with getting the full ... a sleep aid designed to help you fall asleep ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
Breaking Medicine News(10 mins):Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Donate Your Break and Save Lives at the River North Blood Drive 2
... the University of Minnesota have found that cerebral malaria is related ... research is published in the current issue of the journal ... Malaria is a leading cause of death ... than 750,000 children a year, is one of the deadliest forms ...
... Mich., July 29 Stryker Corporation,(NYSE: SYK ) ... conference:, August 6, 2008 - 11:15 a.m. ... Conference New York, New York, A simultaneous ... website at http://www.stryker.com via the For Investors ...
... show that regular,monitoring of medications by physicians is ... health. Thanks to recent advances in the SMART,Registry, ... about their,patients that they never received before., ... how regularly,their chronically ill patients fill their prescriptions., ...
... developed a novel approach to treating advanced prostate cancer ... , Professor Wayne Tilley and Dr Lisa Butler of ... discovered that by using existing prostate cancer drugs in ... expect to generate better results for patients than current ...
... up in motor neurons , , TUESDAY, July 29 (HealthDay ... amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig,s ... University and Harvard Medical School. , ALS is a ... neurons in the brain and spinal cord that control ...
... the Clinical Gold Standard Drug Through 2016, According ... to a New Report from Decision Resources, ... the,world,s leading research and advisory firms focusing on pharmaceutical and,healthcare ... has a lower discontinuation rate than that of Abbott,s,Niaspan ER ...
Cached Medicine News:Health News:U of M researchers find cerebral malaria may be a major cause of brain injury in African children 2Health News:Stryker To Present at Investor Conference 2Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 2Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 3Health News:New treatment for advanced prostate cancer 2Health News:Scientists ID 'Jekyll-Hyde' Protein in Lou Gehrig's Disease 2Health News:A High-Density Lipoprotein Raising Drug That Has a Lower Discontinuation Rate Than That of Extended Release Niaspan Would Earn a 20 Percent Patient Share in the Dyslipidemia Drug Market 2
(Date:5/27/2015)... May 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/hxhwtv/asia_pacific ... Pacific Fluoroscopy Market - Growth, Trends And Forecasts (2014 ... The Asia Pacific market ... CAGR from 2014 to 2020 Fluoroscopy is ... moving images of the interior of the body. The ...
(Date:5/27/2015)... a senior marketing associate with the animal health division of Eli Lilly ... healthcare setting in Bangkok, Thailand , will be among ... with respect and dignity is the guiding star for me and my ... a LillyPad blog . Donatelli and Lilly colleagues from ... Colombia , France , Ukraine ...
(Date:5/27/2015)... , May 25, 2015 Research ... of the "2015 Strategies in the Global ... This comprehensive seven-country report contains 650 ... current suppliers and potential market entrants identify and ... testing market during the next five years. ...
Breaking Medicine Technology:Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3Global Coagulation Testing Market Strategies 2015 2Global Coagulation Testing Market Strategies 2015 3
... Sept. 20 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... of,cethromycin, the Company,s lead compound, at the 47th ... September,17 - 20. A total of seven poster ... Eurofins Medinet and Micromyx, discussed in vitro,activity of ...
... -- When compared to insulin glargine, exenatide offered ... beta-cell function when used with metformin --, ... AMLN ) and Eli Lilly and Company ... treatment of exenatide injection,with insulin glargine on beta-cell ...
Cached Medicine Technology:Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: